Polymyxins

Polymyxins are cationic polypeptide antibiotics that attack the outer membrane of gram-negative bacteria by binding lipopolysaccharide (LPS) and causing cell death. In Microbiology, they show up as last-line drugs for tough resistant infections.

What are polymyxins?

Polymyxins are a class of antibiotics in Microbiology that target the outer membrane of gram-negative bacteria. The main clinical drugs are polymyxin B and colistin, and both are usually reserved for infections that other antibiotics cannot control.

Their main job is not to block protein synthesis or DNA replication. Instead, they act like membrane breakers. Polymyxins are positively charged, so they bind to the negatively charged lipopolysaccharide (LPS) in the outer membrane of gram-negative cells. That binding displaces stabilizing cations like calcium and magnesium, which weakens the membrane structure.

Once the membrane is destabilized, the cell loses its barrier function. Ions and water move out of balance, membrane proteins stop working normally, and the bacterium can lyse. That is why polymyxins are described as cell membrane disruptors, not as drugs that quietly slow growth.

This mechanism matters because gram-negative bacteria have an outer membrane that already makes them harder to kill than many gram-positive bacteria. Polymyxins exploit that structure directly. They are especially associated with multidrug-resistant infections, where the pathogen has already evaded more common drug classes.

Microbiology classes often connect this term to the idea of selective toxicity. Polymyxins are toxic enough that they cannot be used casually, so dosing and monitoring matter. Their use is limited by nephrotoxicity and neurotoxicity, which is why they are treated as last-resort therapy rather than everyday antibiotics.

Resistance usually comes from changes to the bacterial membrane, especially LPS modification that reduces drug binding. If the target changes, the antibiotic cannot attach as well, and the whole membrane-disruption process becomes less effective. So when you see polymyxins, think membrane target, gram-negative bacteria, and a high-stakes fallback drug.

Why polymyxins matter in MICROBIO

Polymyxins sit right in the middle of drug resistance, which is a major topic in Microbiology. They show what happens when common antibiotic classes fail and clinicians have to reach for a drug that still works against stubborn gram-negative pathogens.

This term also helps you connect bacterial structure to drug action. If you know that gram-negative bacteria have an outer membrane with LPS, the polymyxin mechanism makes sense instead of feeling random. The antibiotic is not “stronger” in a vague way, it is built to bind a specific membrane feature.

You will also see polymyxins in discussions of toxicity and treatment tradeoffs. A drug can be effective and still be used cautiously because it harms the kidneys or nervous system. That balance comes up often in antibiotic choice, especially with multidrug-resistant infections.

Finally, polymyxins are a good example of how bacteria can escape antibiotics by changing surface chemistry. That idea connects to broader resistance concepts, especially when you compare membrane-targeting drugs with antibiotics that hit cell wall or protein synthesis targets.

How polymyxins connect across the course

Gram-negative Bacteria

Polymyxins work best on gram-negative cells because they target the outer membrane, especially the LPS layer. If you remember the gram stain difference, this term helps explain why some drugs are narrow in who they can hit. Gram-negative structure is the reason polymyxins have a clear target.

Cell Membrane Disruption

This is the mechanism behind polymyxins. Instead of blocking an enzyme, the drug destabilizes the membrane so the cell cannot maintain homeostasis. In Microbiology questions, this helps you predict that the result is leakage, lysis, and cell death.

Nephrotoxicity

Polymyxins are famous for kidney toxicity, so this term often appears right alongside the drug name. When you see a question about why a drug is limited or monitored closely, nephrotoxicity is usually the answer. It is one reason polymyxins are reserved for severe infections.

Antibiotic Stewardship

Polymyxins are a good example of why antibiotic stewardship matters. Because they are last-line drugs with serious side effects, they should be used only when needed and with the right dose. Stewardship keeps resistance from spreading and protects drugs like colistin for cases that truly need them.

Are polymyxins on the MICROBIO exam?

A quiz or short-answer question may ask you to match polymyxins with their target, and you should identify the gram-negative outer membrane or LPS. In a case study, you might explain why a patient with a multidrug-resistant gram-negative infection is being treated with colistin instead of a first-line antibiotic. If the question gives a mechanism, trace the cause and effect: binding to LPS, membrane disruption, lysis, and bacterial death. If toxicity is mentioned, connect the drug choice to kidney or nerve side effects and explain why monitoring matters. On lab or discussion questions, you may also be asked why polymyxins are not used casually, which gets at stewardship and resistance.

Polymyxins vs Beta-Lactamases

These are easy to mix up because both show up in drug-resistance discussions. Polymyxins are antibiotics that attack the gram-negative membrane, while beta-lactamases are bacterial enzymes that break down beta-lactam antibiotics. One is a drug class, the other is a resistance mechanism.

Key things to remember about polymyxins

• Polymyxins are last-resort antibiotics used mainly against multidrug-resistant gram-negative bacteria.

• They work by binding to LPS in the outer membrane and disrupting membrane integrity.

• Because the membrane fails, the bacterial cell loses control of its contents and can lyse.

• Polymyxin B and colistin are the main clinical examples you are likely to see.

• Their use is limited by nephrotoxicity and neurotoxicity, so monitoring matters.

Frequently asked questions about polymyxins

What is Polymyxins in Microbiology?

Polymyxins are a group of cationic polypeptide antibiotics that kill gram-negative bacteria by damaging the outer membrane. In Microbiology, they are usually discussed as last-line drugs for resistant infections. The most familiar examples are polymyxin B and colistin.

How do polymyxins work?

They bind to lipopolysaccharide, or LPS, in the gram-negative outer membrane. That binding destabilizes the membrane, causes leakage, and can lead to cell lysis. The mechanism is physical membrane damage, not inhibition of protein or DNA synthesis.

Why are polymyxins considered last-resort antibiotics?

They are held back because they can cause serious side effects, especially nephrotoxicity and neurotoxicity. They are also mainly used when infections are caused by multidrug-resistant gram-negative bacteria that do not respond to safer options. That makes them valuable, but not a first choice.

How do bacteria become resistant to polymyxins?

A common strategy is modifying the LPS or outer membrane so the drug cannot bind as well. When the target changes, the antibiotic loses much of its ability to disrupt the membrane. That is why resistance often reduces polymyxin effectiveness quickly.